← Insulin × glycemic control

TrialThe review of diabetic studies : RDS

Inverse Association of Peripheral Orexin-A with Insulin Resistance in Type 2 Diabetes Mellitus: A Randomized Clinical Trial.

Mitra Zarifkar et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported

No range given

Reported higher glycemic control, no range given

+26.0percentage points

As reported

difference 26 %, no interval

One number in the abstract

the abstract, start to end

… and increased orexin concentrations by 26% (p = 0.025) and 14% (p = …

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
26
MetforminThiazolidinedionesInsulinGlycemic control
1 / 3

10 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29145540